| Dr Byung Nam Lee, DC | |
|
7411 Riggs Rd, Ste 219, Adephi, MD 20783-4246 | |
| (571) 276-6331 | |
| Not Available |
| Full Name | Dr Byung Nam Lee |
|---|---|
| Gender | Male |
| Speciality | Chiropractor |
| Location | 7411 Riggs Rd, Adephi, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558890780 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 0104-557457 (Virginia) | Secondary |
| 111N00000X | Chiropractor | S04008 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Byung Nam Lee, DC 5502 Newhall Ct, Centreville, VA 20120-2088 Ph: (571) 276-6331 | Dr Byung Nam Lee, DC 7411 Riggs Rd, Ste 219, Adephi, MD 20783-4246 Ph: (571) 276-6331 |
News Archive
Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, can significantly reduce or even eliminate their need for expensive and time-consuming apheresis treatments with the PCSK9 inhibitor alirocumab.
A ninth-grade ethnic studies class has a remarkably prolonged and strong positive impact on students, increasing their overall engagement in school, probability of graduating and likelihood of enrolling in college, according to a new study of a curriculum offered at the San Francisco Unified School District (SFUSD).
Unilens Vision Inc. today announced the Company completed the Stock Purchase Agreement announced on November 9, 2009, in which it repurchased 2,188,861 shares of its common stock, representing approximately 48% of it's outstanding shares, from its largest shareholder, Uniinvest Holding AG in Liquidation (Uniinvest) for an aggregate purchase price of US $6,894,912 or $3.15 per share.
One out of every six American women has experienced a sexual assault or an attempted sexual assault or rape in her lifetime, according to the National Institute of Justice and the Centers for Disease Control and Prevention.
The first child stem cell-supported trachea transplant is functioning well two years on, according to an Article published Online First in The Lancet today. The follow-up of the procedure, carried out in 2010 at Great Ormond Street Hospital (GOSH), shows that the new organ has strengthened and does not appear to have induced any signs of rejection. The 13-year-old boy who received the transplant continues to breathe normally, has grown 11 cm in height and has returned to school. He does not require any anti-rejection therapy.
› Verified 3 days ago